S&P 500   4,444.69 (-0.10%)
DOW   34,729.15 (-0.10%)
QQQ   371.53 (-0.39%)
AAPL   146.10 (-0.50%)
MSFT   298.04 (-0.51%)
FB   347.40 (+0.42%)
GOOGL   2,830.20 (+0.21%)
TSLA   761.57 (+1.05%)
AMZN   3,400.17 (-0.46%)
NVDA   219.31 (-2.45%)
BABA   145.97 (-3.45%)
NIO   35.46 (-1.53%)
CGC   13.99 (-3.91%)
GE   104.15 (+1.16%)
MU   74.34 (+0.41%)
AMD   105.26 (-0.84%)
T   27.29 (+0.37%)
F   13.94 (+1.68%)
ACB   6.02 (-2.11%)
DIS   175.53 (-0.41%)
PFE   44.12 (-0.16%)
BA   221.70 (+0.27%)
BAC   42.15 (+1.10%)
S&P 500   4,444.69 (-0.10%)
DOW   34,729.15 (-0.10%)
QQQ   371.53 (-0.39%)
AAPL   146.10 (-0.50%)
MSFT   298.04 (-0.51%)
FB   347.40 (+0.42%)
GOOGL   2,830.20 (+0.21%)
TSLA   761.57 (+1.05%)
AMZN   3,400.17 (-0.46%)
NVDA   219.31 (-2.45%)
BABA   145.97 (-3.45%)
NIO   35.46 (-1.53%)
CGC   13.99 (-3.91%)
GE   104.15 (+1.16%)
MU   74.34 (+0.41%)
AMD   105.26 (-0.84%)
T   27.29 (+0.37%)
F   13.94 (+1.68%)
ACB   6.02 (-2.11%)
DIS   175.53 (-0.41%)
PFE   44.12 (-0.16%)
BA   221.70 (+0.27%)
BAC   42.15 (+1.10%)
S&P 500   4,444.69 (-0.10%)
DOW   34,729.15 (-0.10%)
QQQ   371.53 (-0.39%)
AAPL   146.10 (-0.50%)
MSFT   298.04 (-0.51%)
FB   347.40 (+0.42%)
GOOGL   2,830.20 (+0.21%)
TSLA   761.57 (+1.05%)
AMZN   3,400.17 (-0.46%)
NVDA   219.31 (-2.45%)
BABA   145.97 (-3.45%)
NIO   35.46 (-1.53%)
CGC   13.99 (-3.91%)
GE   104.15 (+1.16%)
MU   74.34 (+0.41%)
AMD   105.26 (-0.84%)
T   27.29 (+0.37%)
F   13.94 (+1.68%)
ACB   6.02 (-2.11%)
DIS   175.53 (-0.41%)
PFE   44.12 (-0.16%)
BA   221.70 (+0.27%)
BAC   42.15 (+1.10%)
S&P 500   4,444.69 (-0.10%)
DOW   34,729.15 (-0.10%)
QQQ   371.53 (-0.39%)
AAPL   146.10 (-0.50%)
MSFT   298.04 (-0.51%)
FB   347.40 (+0.42%)
GOOGL   2,830.20 (+0.21%)
TSLA   761.57 (+1.05%)
AMZN   3,400.17 (-0.46%)
NVDA   219.31 (-2.45%)
BABA   145.97 (-3.45%)
NIO   35.46 (-1.53%)
CGC   13.99 (-3.91%)
GE   104.15 (+1.16%)
MU   74.34 (+0.41%)
AMD   105.26 (-0.84%)
T   27.29 (+0.37%)
F   13.94 (+1.68%)
ACB   6.02 (-2.11%)
DIS   175.53 (-0.41%)
PFE   44.12 (-0.16%)
BA   221.70 (+0.27%)
BAC   42.15 (+1.10%)
CVE:XLY

Auxly Cannabis Group Stock Forecast, Price & News

C$0.39
+0.02 (+5.41 %)
(As of 04/19/2021)
Add
Compare
Today's Range
C$0.38
C$0.40
50-Day Range
C$0.39
C$0.39
52-Week Range
C$0.12
C$0.51
Volume1.63 million shs
Average Volume2.25 million shs
Market CapitalizationC$289.90 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive XLY News and Ratings via Email

Sign-up to receive the latest news and ratings for Auxly Cannabis Group and its competitors with MarketBeat's FREE daily newsletter.


Auxly Cannabis Group logo

About Auxly Cannabis Group

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.25 out of 5 stars

Analyst Opinion: 1.3Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Auxly Cannabis Group (CVE:XLY) Frequently Asked Questions

Is Auxly Cannabis Group a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Auxly Cannabis Group in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Auxly Cannabis Group stock.
View analyst ratings for Auxly Cannabis Group
or view top-rated stocks.

What stocks does MarketBeat like better than Auxly Cannabis Group?

Wall Street analysts have given Auxly Cannabis Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Auxly Cannabis Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Auxly Cannabis Group's stock price been impacted by Coronavirus (COVID-19)?

Auxly Cannabis Group's stock was trading at C$0.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XLY shares have increased by 8.3% and is now trading at C$0.39.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for XLY?

3 equities research analysts have issued 1 year price targets for Auxly Cannabis Group's stock. Their forecasts range from C$0.40 to C$0.45. On average, they anticipate Auxly Cannabis Group's stock price to reach C$0.43 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price.
View analysts' price targets for Auxly Cannabis Group
or view top-rated stocks among Wall Street analysts.

Who are Auxly Cannabis Group's key executives?

Auxly Cannabis Group's management team includes the following people:
  • Mr. Hugo M. Alves, CEO & Director (Age 49, Pay $543k)
  • Mr. Brian Schmitt, Chief Financial Officer
  • Mr. Michael David Lickver, Pres (Age 36)
  • Mr. Alan Cooke, Sr. VP of Operations
  • Ms. Carla Nawrocki, VP of Investor Relations, Corp. Devel. & Stakeholder Relations
  • Mr. Ron Fichter, Gen. Counsel & Corp. Sec.
  • Mr. Ian Peter Rapsey, Chief Creative Officer (Age 44)
  • Mr. Kevin Furet, Chief Cultivation & Genetics Officer
  • Mr. Andrew MacMillan, Sr. VP of Commercial

What other stocks do shareholders of Auxly Cannabis Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Auxly Cannabis Group investors own include Auxly Cannabis Group (CBWTF), (VNRSQ) (VNRSQ), Aurora Cannabis (ACB), (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), (APHA), OrganiGram (OGI), Alibaba Group (BABA) and CannTrust (CTST).

What is Auxly Cannabis Group's stock symbol?

Auxly Cannabis Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "XLY."

How do I buy shares of Auxly Cannabis Group?

Shares of XLY and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Auxly Cannabis Group's stock price today?

One share of XLY stock can currently be purchased for approximately C$0.39.

How much money does Auxly Cannabis Group make?

Auxly Cannabis Group has a market capitalization of C$289.90 million and generates C$35.07 million in revenue each year.

What is Auxly Cannabis Group's official website?

The official website for Auxly Cannabis Group is www.auxly.com.

How can I contact Auxly Cannabis Group?

The company can be reached via phone at 833-695-2414.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.